Please respond by August 1, 2022.
*NaRCAD is a program of the Boston Medical Center. This communication has been CC'ed to our colleagues at San Francisco Department of Public Health. The opportunity to partner with NaRCAD is not affiliated with SFDPH. Organizations may choose to participate or not; technical assistance services from SFDPH will not be impacted.
Background: Since 1981, more than 700,000 American lives have been lost to HIV. HIV pre-exposure prophylaxis (PrEP) decreases HIV incidence by up to 99% when adherence is high, and HIV incidence is decreasing in regions where PrEP uptake is highest. Thus, PrEP is a potent tool to curtail the HIV epidemic, and its scale-up is a critical goal of the federal Ending the HIV Epidemic (EHE) initiative. Academic detailing (AD) has been increasingly adopted as a method to increase PrEP prescribing, especially in primary care. We’ve learned that during the COVID-19 pandemic, many organizations implementing AD to increase PrEP uptake have been forced to switch to delivering AD virtually, connecting with clinicians via videoconference rather than in person.
Stigma can act as a barrier to HIV testing and care as well as access to PrEP. Clinician stigma can manifest in many forms, much of which is implicit, making it challenging to address with AD or other interventions. Developing a more nuanced understanding of clinician stigma and how it affects attitudes and behaviors related to PrEP can support the development of more effective AD interventions. The rise in the use of virtual AD creates an opportunity for us to study this important issue by capturing recordings of the detailing visits and conducting careful analyses of the interactions you’re having with clinicians.
Study overview: Our team from the National Resource Center for Academic Detailing (NaRCAD) is based at Boston Medical Center (BMC), where we collaborate with clinical and research faculty with expertise in HIV care, PrEP delivery, and evaluation of clinician stigma. For this proposed study, we seek to collaborate with public health organizations conducting virtual AD seeking to increase PrEP uptake. Virtual AD sessions will be recorded and will provide the primary study data.
Potential for Impact: We’ll use the results of this study as the foundation for the development of AD interventions to address clinician stigma. This collaboration will provide an exciting opportunity to participate in and study the impact of virtual AD for better patient outcomes related to HIV prevention.
We’ll evaluate the content of each virtual session and themes will be identified and assessed. The analyses will focus on themes related to clinician stigma, though other major trends will also be evaluated. You’ll have the opportunity to collaborate on the development of presentations and manuscripts resulting from this study.
How We’ll help: Our team at NaRCAD will provide ongoing technical assistance to assist with implementation, logistics, and capturing data. We’ll have a kick-off call to walk through the details and continue to provide support through check-in calls as needed. You’ll also have a point of contact on the NaRCAD team who you’ll be able to email if challenges come up.
Interested? Next Steps:
Background: Since 1981, more than 700,000 American lives have been lost to HIV. HIV pre-exposure prophylaxis (PrEP) decreases HIV incidence by up to 99% when adherence is high, and HIV incidence is decreasing in regions where PrEP uptake is highest. Thus, PrEP is a potent tool to curtail the HIV epidemic, and its scale-up is a critical goal of the federal Ending the HIV Epidemic (EHE) initiative. Academic detailing (AD) has been increasingly adopted as a method to increase PrEP prescribing, especially in primary care. We’ve learned that during the COVID-19 pandemic, many organizations implementing AD to increase PrEP uptake have been forced to switch to delivering AD virtually, connecting with clinicians via videoconference rather than in person.
Stigma can act as a barrier to HIV testing and care as well as access to PrEP. Clinician stigma can manifest in many forms, much of which is implicit, making it challenging to address with AD or other interventions. Developing a more nuanced understanding of clinician stigma and how it affects attitudes and behaviors related to PrEP can support the development of more effective AD interventions. The rise in the use of virtual AD creates an opportunity for us to study this important issue by capturing recordings of the detailing visits and conducting careful analyses of the interactions you’re having with clinicians.
Study overview: Our team from the National Resource Center for Academic Detailing (NaRCAD) is based at Boston Medical Center (BMC), where we collaborate with clinical and research faculty with expertise in HIV care, PrEP delivery, and evaluation of clinician stigma. For this proposed study, we seek to collaborate with public health organizations conducting virtual AD seeking to increase PrEP uptake. Virtual AD sessions will be recorded and will provide the primary study data.
Potential for Impact: We’ll use the results of this study as the foundation for the development of AD interventions to address clinician stigma. This collaboration will provide an exciting opportunity to participate in and study the impact of virtual AD for better patient outcomes related to HIV prevention.
We’ll evaluate the content of each virtual session and themes will be identified and assessed. The analyses will focus on themes related to clinician stigma, though other major trends will also be evaluated. You’ll have the opportunity to collaborate on the development of presentations and manuscripts resulting from this study.
How We’ll help: Our team at NaRCAD will provide ongoing technical assistance to assist with implementation, logistics, and capturing data. We’ll have a kick-off call to walk through the details and continue to provide support through check-in calls as needed. You’ll also have a point of contact on the NaRCAD team who you’ll be able to email if challenges come up.
Interested? Next Steps:
- Interested organizations should have academic detailers who have been trained in the techniques of AD, who have been in the field for a minimum of 3-6 months and are currently delivering virtual AD sessions focused on PrEP uptake.
- Any organization interested in participating should complete our interest form by August 1, 2022. If you have additional questions, please contact Anna Morgan-Barsamian, MPH, RN, PMP, Senior Manager, Training & Education, NaRCAD at [email protected]